TNF and COVID-19: Since TNF-α is an initial driver of NF-κB activation and involved in the expression of several pro-inflammatory and anti-apoptotic genes in SARS-CoV-2 infection, its inhibition can attenuate excessive cytokine release and hyperinflammation in COVID-19 (28, 197, 277, 278).